Rheumatology & Autoimmune

Arthritis, lupus, vasculitis, biologics, and immune‑modulating therapies.

  • 3 Tracked terms
  • Last 30 days Feed window

What this topic collects on

An article joins this feed when it matches these terms. Each one is also a search of its own.

Latest in Rheumatology & Autoimmune


tripurastarnews.com > beyond-joint-pain-why-early-recognition-of-autoimmune-arthritis-can-change-long-term-outcomes-dr-anirudh-maslekar-attending-consultant-rheumatology-kims-hospitals-mahadevapur

Beyond Joint Pain??? Why Early Recognition Of Autoimmune Arthritis Can Change Long-Term Outcomes: Dr. Anirudh Maslekar, Attending Consultant??? Rheumatology, KIMS Hospitals, Mahadevapura, Bengaluru.

1+ hour, 41+ min ago   (397+ words) But in a clinically significant subset of patients, joint pain is the presenting symptom of an autoimmune condition in which the immune system is attacking the joint lining, and the distinction matters enormously for what happens next. The Diagnostic Window…...


sjogrenssyndromenews.com > news > study-links-salivary-gland-swelling-distinct-sjogrens-profile

Study links salivary gland swelling to distinct Sjögren’s profile

11+ hour, 46+ min ago   (682+ words) Major gland swelling without dry mouth may point to specific disease pattern Written by Andrea Lobo, PhD | Sept. 23, 2026 Swelling of the major salivary glands without dry mouth at the time of a Sjögren’s disease diagnosis may point to a distinct…...


biospace.com > drug-development > immunovant-ditches-lupus-for-multi-hyphenate-inflammatory-drug-after-mid-stage-miss

Immunovant ditches lupus for multi-hyphenate inflammatory drug after mid-stage miss

6+ hour, 32+ min ago   (262+ words) Man making decision what path, direction to take. Arrows pointing in different directions Immunovant’s proof-of-concept trial for IMVT-1402 has failed to meet the company’s bar for efficacy in lupus and will be discontinued, with analysts brushing off the low-priority indication....


finance.yahoo.com > healthcare > articles > immunovant-pulls-plug-lupus-program-123256433.html

Immunovant Pulls Plug On Lupus Program After Study Misses Primary Goal — IMVT Stock Heads For Over 3-Month Lows

14+ hour, 42+ min ago   (389+ words) Immunovant plans to stop drug development for CLE, given the "competitive landscape The biotech firm had $797.8 million in cash as of June 30 and expects its resources to fund operations through a potential IMVT-1402 launch in Graves' disease. Shares of Immunovant…...


innovationnewsnetwork.com > 50m-uk-centre-to-develop-new-inflammatory-diseases-treatments > 74204

£50m UK research centre to develop new treatments for inflammatory diseases

18+ hour, 12+ min ago   (601+ words) Led by the University of Birmingham, the centre will bring together scientists, clinicians and patient research partners from the UK and Japan. The new MRC Centre of Research Excellence (CoRE) in Restorative Immunology will investigate why immune-mediated diseases (IMIDs) develop…...


newschannel9.com > this-n-that > new-approach-to-autoimmune-wellness

New approach to autoimmune wellness

1+ day, 5+ hour ago   (126+ words) WTVC Do you or someone you know live with an autoimmune disease? Autoimmune conditions occur when the body's immune system mistakenly attacks healthy cells, tissues, and organs instead of protecting against harmful germs. Kevin Bragg with Bragg Weight Loss discusses…...


lupus.org > blog > racing-to-end-lupus-with-the-philadelphia-marathon-team

Racing to End Lupus with the Philadelphia Marathon Team

1+ day, 15+ hour ago   (588+ words) This Fall, 34 Racing to End Lupus team members will be making their miles matter during the Philadelphia Marathon Weekend – taking on the marathon, half marathon and 8K races. Over the last several months, each member of the team has not only…...


allsci.com > news > approvals > rinvoq-juvenile-idiopathic-arthritis-european

AbbVie's Rinvoq picks up EU nod for polyarticular juvenile idiopathic arthritis in children

1+ day, 17+ hour ago   (520+ words) AllSci Children as young as two years old in Europe now have access to an oral JAK inhibitor option for polyarticular juvenile idiopathic arthritis (pJIA), after the European Commission approved upadacitinib (Rinvoq) for the indication in patients who have responded…...


wmar2news.com > homepage-showcase > were-not-in-this-fight-alone-walk-to-end-lupus-now-baltimore-raises-more-than-68k

‘We’re not in this fight alone’: Walk to End Lupus Now Baltimore raises more than $68K

2+ day, 9+ hour ago   (384+ words) BALTIMORE — "It has impacted me tremendously. It may not look like it, but it definitely has. I have days that I can barely get up and move," Rita Wells said. Wells was diagnosed with lupus in 2017. What has kept her…...